Karolinska Development AB (publ) – Interim Report

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Karolinska Development AB (publ) – Interim Report January – March 2015

Jim Van heusden, CEO, comments: “During my first two months as CEO at Karolinska Development I started to evaluate our portfolio assets in more detail and I continue to be impressed by the high-quality science.  That said, I also see some challenges in translating that science into a real investment case for some of our portfolio companies, which is essential to generate superior returns on invested capital.  As a consequence, we have taken and will need to take further difficult decisions in order to focus our resources on those companies that have the greatest potential to generate attractive returns to our shareholders.

One of the things I would like to improve is the transparency of the way we work.  Together with my team we are fully committed to strengthen our corporate communication which should become evident in the months to come. We will provide more openness into our financial reporting. The valuation of our portfolio companies is a key financial metric in evaluating progress in our portfolio. We are looking into alternatives that are more transparent and less sensitive to incidental variations that have a high impact on valuation. We also need to strengthen our internal organizational structures and team, and are in the process of strengthening our portfolio companies on both the management and board level.

One of the priorities in our investment strategy is to attract new investments from experienced international life sciences investors. As such we are able to share the risks and gain access to other investors’ network and expertise. We are currently in discussions with co-investors for a number of our portfolio companies. Besides fundraising, we are also exploring other options such as licensing, M&A or other creative solutions.  An example of the latter is the sale of Axelar to Östersjöstiftelsen (The Foundation for Baltic and East European Studies) where the company can continue its development efforts and we retain potential upside via an earn-out agreement without requiring further investments from us. Unfortunately, we also need to let companies go where we don’t see any further value despite extensive efforts in relation to financing, licensing and M&A to find a solution for them. This was the case for example for the opportunistic companies Pergamum, Umecrine Mood and NeoDynamics which we recently announced to write-off completely. While such outcomes in our portfolio are not satisfactory, we also realize this is a risk that all investors within this sector are faced with.

We are now focusing on the portfolio companies that have the highest potential to generate attractive returns. We look forward to the continued development in Aprea, as the company presented the first preliminary results from its Phase I/II clinical trial in ovarian cancer in April. Dilaforette is in final preparation to initiate their Phase II trial in sickle-cell disease where patients regularly suffer from painful crises that require intensive-care treatment. We will continue to report progress in our portfolio companies to the market, but need to point out that given the early stage nature of the companies we have invested in, we also need to have patience in order to be able to unlock their full value potential.”

 

Summary of significant events during the first quarter 2015

Karolinska Development

  • Karolinska Development finalized the company’s financing through the issue of convertibles by an additional subscription of SEK 39 million and the confirmation of full payment of SEK 100 million from Thai Charoen Pokphand Group (CP Group)
  • Jim Van heusden appointed CEO of Karolinska Development
  • Karolinska Development sold its stake in Axelar to Östersjöstiftelsen (The Foundation for Baltic and East European Studies)

 The Portfolio

  • Dilaforette announced co-development agreement with Ergomed
  • Dilaforette received Orphan Drug Designation by the U.S. FDA for sevuparin in sickle-cell disease
  • Clanotech granted Orphan Drug Designation by the U.S. FDA

 

Summary of significant events after the first quarter 2015

  • Aprea presented preliminary Phase Ib/II results in ovarian cancer with APR-246 at the American Association for Cancer Research (AACR) Annual Meeting
  • Karolinska Development announced fair value decrease included in the first quarter results amounting to SEK -225.2 million mainly due to write-offs of three opportunistic portfolio companies

 

Financial summary

SEKm     2015 Jan-Mar 2014 Jan-Mar 2014 Full-year
Condensed income statement          
Change in fair value in portfolio companies     -252.7 -6.1 -310.4
Net profit/loss     -275.1 -18.4 -375.8
Condensed balance sheet          
Cash, cash equivalents and short-term investments   440.4 171.0 141.3
Share information          
Earnings per share, weighted average, before and after dilution (SEK)     -5.2 -0.4 -7.7
Net asset value per share (SEK)     27.5 40.3 30.8
Equity per share (SEK)     26.7 40.2 31.0
Share price, last trading day in the reporting period (SEK)   11.5 26.3 13.3
Portfolio information          
Portfolio companies' net cash¹     67.6 74.6 55.0
Investments in portfolio companies     2.5 15.5 84.0
Of which investments not affecting cash flow     - - 6.7
Fair value of portfolio holdings     1,277.0 1,738.9 1,502.2
¹ Portfolio companies' net cash is comprised of sum of cash, cash equivalents and short-term investments less external loans in  portfolio companies regardless of Karolinska Development's ownership interest

 

For further information, please contact: Jim Van heusden, CEO, Karolinska Development AB Phone: +46 72 858 32 09, e-mail: jim.van.heusden@karolinskadevelopment.com

Christian Tange, CFO, Karolinska Development AB Phone: +46 73 712 14 30, e-mail: christian.tange@karolinskadevelopment.com

 

 

 

TO THE EDITORS

About Karolinska Development AB Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into differentiated products that can be partnered. The business model is to: SELECT the most commercially attractive medical innovations that can potentially satisfy unmet medical needs; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products. An exclusive deal flow agreement with Karolinska Institutet Innovations AB, along with other cooperation agreements with leading universities, delivers a continuous flow of innovations. For more information, please visit www.karolinskadevelopment.com.

Karolinska Development is listed on NASDAQ OMX (STO: KDEV). Karolinska Development may be required to disclose the information provided herein pursuant to the Securities Markets Act.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 128

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 81

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 141

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 47

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 81

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Toledo Crosswalk Death Lawsuit Raises Hard Questions

Updated Category News Views 144

A painted crosswalk is supposed to mean something, and that is the grim center of the lawsuit filed over Judy Tanner’s death in Toledo. Tanner, 20, was walking home from work on September 10, 2026, when she was struck and killed while crossing the street. Her estate is now suing, alleging that the 31-year-old driver failed to yield as Tanner legally used the crosswalk....

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Inhabit Puts AI Across Its Property Management Stack

Updated Category News Views 37

Property managers do not need another shiny chatbot; they need fewer dropped leads, fewer invoice-entry mistakes and less staff time burned chasing routine answers. That is the sensible hook in Inhabit's OPTECH 2026 announcement. The company is spreading AI, integrations and scalability work across ResMan, Anyone Home, ePremium, Nationwide Compliant and several adjacent...

Continue Reading

Top 5 Most Recently Viewed Articles

Skylark Labs Enhances Mobility Analytics with New Contracts

Updated Category News Views 259

Transforming Mobility Analytics Skylark Labs is at the forefront of innovation as it takes significant strides to transform mobility analytics. The company recently announced its success in securing multiple contracts aimed at deploying its advanced Scout Towers throughout busy highways. Empowering the Indiana DOT The focus of these contracts is primarily on empowering...

Continue Reading
Arm Collaborates with Malaysia on $250 Million Chip Initiative

Updated Category News Views 201

Introduction to the Exciting Partnership Arm Holdings – ADR (NASDAQ: ARM), a dynamic subsidiary of SoftBank Group Corp. (OTC: SFTBY), has embarked on a groundbreaking partnership with Malaysia, sealing a monumental $250 million deal. This agreement aims to significantly enhance chip design and technology services over the next decade, marking a pivotal moment in both...

Continue Reading
Music Licensing, Inc. (OTC: SONG) Implements New Share Classes

Updated Category News Views 119

Music Licensing, Inc. Unveils New Share Classes and Forward Stock Split Music Licensing, Inc. (OTC: SONG), a well-known leader in music rights management, is making substantial moves to improve its stock market standing. Recently, the company faced some challenges, including an unsuccessful reverse stock split. In response to these hurdles, they are proactively addressing...

Continue Reading
Exploring Legal Actions for Venture Global, Inc. Investors

Updated Category News Views 368

Latest Developments for Venture Global, Inc. Investors Venture Global, Inc. is currently under scrutiny as a class-action lawsuit has been initiated on behalf of its investors. This follows significant developments surrounding the company's operations and interactions with major clients. Understanding the Class Action Lawsuit The lawsuit focuses on the concerns raised by...

Continue Reading
STL and Colt Together Pioneer Multi-Core Fibre Trials for The Future

Updated Category News Views 112

Innovation in Optical Connectivity: The STL and Colt Collaboration In a groundbreaking development, STL (NSE: STLTECH), a renowned connectivity solutions provider, has successfully partnered with Colt Technology Services to conduct trials of their innovative Multi-Core Fibre (MCF). This initiative, executed within Colt's expansive optical network in an urban setting,...

Continue Reading